Isatoribine hydrate

Catalog No. :
ACWDXG217
CAS No. :
198832-38-1
Molecular Formula :
C10H14N4O7S
Molecular Weight :
334.31

IUPAC Name:5-amino-3-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)thiazolo[4,5-d]pyrimidine-2,7(3H,6H)-dione hydrate

Isatoribine hydrate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameIsatoribine hydrate
IUPAC Name5-amino-3-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)thiazolo[4,5-d]pyrimidine-2,7(3H,6H)-dione hydrate
Molecular FormulaC10H14N4O7S
Molecular Weight334.31
SMILESO=C(N1[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)SC3=C1N=C(N)NC3=O.[H]O[H]
InChI KeyBZWQQOVSUSJJJO-QAGDRQIHSA-N
Synonym5-Amino-3-beta-D-ribofuranosylthiazolo[4,5-d]pyrimidine-2,7(3H,6H)-dione monohydrate;Isatoribine hydrate;Isatoribine [usan:ban];Thiazolo(4,5-D)pyrimidine-2,7(3H,4H)-dione, 5-amino-3-beta-D-ribofuranosyl-, monohydrate;ANA245;ANA245;IMMUSINE;ISATORIBINEHYDRATE;ISATORIBINEMONOHYDRATE;D04619;D04619;Immusine
CAS No.198832-38-1

Synthetic Route by SureRoute

1. ACWDXG217 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACWDXG217 route product structure diagram
    ACWDXG217198832-38-1
Inquiry

2. ACWDXG217 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACWDXG217 route product structure diagram
    ACWDXG217198832-38-1
Inquiry

Comments (0)